Magnite Surges 11% on BofA's $38 Target — But Can a Six-Year Court Remedy Really Deliver a 46% Upside?

Shares jumped as Bank of America hiked its price target on Magnite by 52% — from $25 to $38 — betting that a federal court's antitrust remedies against Google will pry open the online advertising market for independent competitors. The upgrade lands in a moment of Wall Street euphoria around ad-tech names, but the real payoff hinges on enforcement timelines investors may be underpricing.

A Court Ruling That Hands Rivals a Shot at Google's Ad Dollars. The court imposed interoperability and data-sharing requirements, anti-discrimination remedies, and prohibitions on Google's self-preferencing bidding behavior. In plain English: Google must build interoperability between its ad exchange and the open-source Prebid project, send bids to rival publisher ad servers on the same terms its own server gets, and stop requiring publishers who use its ad server to also use its exchange. Bank of America estimates these changes could lift Magnite's share of open-web display advertising to 8%–10%, up from roughly 6% today. Magnite itself estimates Google holds roughly 60% of the relevant market.

The Revenue Impact Is Real but Distant. The remedies run for six years , and nothing shifts for Magnite's revenue until Google builds the required integrations.

Magnite has not incorporated potential benefits from antitrust remedies into its forecasts or guidance. That means Bank of America's $38 target prices in upside the company itself refuses to model. Investors are buying a legal process, not a quarterly beat.

The Underlying Business Is Already Accelerating. Independent of the Google case, Magnite reported Q2 2026 revenue of $192.8 million, up 11% year-over-year, with CTV contribution growing 36% to $97.1 million and adjusted EBITDA rising 30% to $70.6 million at a 37% margin.

Full-year guidance calls for at least 11% growth and an EBITDA margin of 35.5% or better. The stock isn't purely a courtroom lottery ticket.

Skeptics Have a Point — History Suggests Caution. Equativ's CEO noted "we have seen this movie before," referencing France's 2021 behavioral remedies against Google that failed to materially shift market share.

Insider selling totaled $17.9 million over the last three months. At $25.95, the stock sits 32% below BofA's target — a gap that requires both legal enforcement and continued CTV momentum to close.